本文選題：財務診斷 + 財務管理優(yōu)化��； 參考：《廣東工業(yè)大學》2017年碩士論文

【摘要】：財務診斷是準確反映企業(yè)經營狀況和經營業(yè)績、發(fā)掘企業(yè)在經營管理方面存在問題的分析方法,財務分析以財務管理優(yōu)化為最終目的,是企業(yè)進行財務診斷工作的分析工具,是管理者進行有效財務管理的基礎條件。目前,我國作為全球第三大醫(yī)藥市場,醫(yī)藥行業(yè)已經成為現代經濟的重要組成部分,作為廣東省醫(yī)藥行業(yè)中發(fā)展較快的公司,ZS面臨公司研發(fā)投入與績效匹配率較低、外延性擴張政策影響下償債能力較弱、成本費用控制能力弱等問題。因此本文以ZS公司為例,分析其經營中的優(yōu)勢與不足,并提出財務管理優(yōu)化建議。本文由七部分組成:第一部分為緒論,主要介紹研究背景及意義、國內外研究現狀、研究內容及方法、研究思路;第二部分是相關概念及基本理論梳理;第三部分是ZS公司基本情況介紹;第四部分是對ZS公司進行診斷分析。首先通過PEST、波特五力模型、SWOT分析從宏觀環(huán)境、行業(yè)現狀、企業(yè)自身優(yōu)劣三方面對企業(yè)進行戰(zhàn)略診斷,其次從公司主要會計政策和估計的變動進行合理的會計診斷,再次立足償債能力、盈利能力、營運能力、現金流量狀況的橫縱向比較,發(fā)現其經營管理中的不足,最后運用前景分析預測公司的發(fā)展趨勢;第五部分是公司財務診斷的綜合評價、存在問題及原因分析;第六部分財務管理優(yōu)化建議;第七部分是結論與展望。本文以ZS公司2011—2015年年報為基礎,通過哈佛分析框架進行財務診斷發(fā)現問題,運用杜邦分析法和連環(huán)替代法找出原因,診斷發(fā)現公司總體發(fā)展呈現積極進取的態(tài)勢,制定較為合理的財務發(fā)展戰(zhàn)略和管理制度,但個別指標由于近年公司并購、市場經濟發(fā)展變緩等原因出現波動或是不良的發(fā)展情況;存貨及應收賬款周轉率較低;產品的開發(fā)戰(zhàn)略執(zhí)行力差強人意,研發(fā)投入的轉化率并沒有大大提高公司的市場占有率;成本控制能力較弱;公司的并購使得短期償債能力減弱,償債風險增加。這需要公司制定財務戰(zhàn)略優(yōu)化設計、完善財務會計管理及披露、提升公司財務績效與運營效率、做好研發(fā)及內外資源協同下的財務前景預測,綜合四方面進行考慮,層層給出具體意見。本文通過概括總結、得出啟示,找出ZS公司發(fā)展的方向,同時對其他醫(yī)藥企業(yè)的經營思路給予借鑒作用。
[Abstract]:Financial diagnosis is an analytical method to accurately reflect the operating status and performance of an enterprise, and to find out the problems existing in the management of an enterprise. The ultimate purpose of financial analysis is to optimize the financial management, which is an analytical tool for the financial diagnosis of an enterprise. Is the manager carries on the effective financial management the foundation condition. At present, as the third largest pharmaceutical market in the world, the pharmaceutical industry has become an important part of the modern economy. As a rapidly developing company in the pharmaceutical industry of Guangdong Province, ZS faces a low matching rate of R & D investment and performance. Under the influence of extraductive expansion policy, the ability to repay debt is weak, and the cost-cost control ability is weak. Therefore, this paper takes ZS Company as an example, analyzes its advantages and disadvantages, and puts forward some suggestions for optimizing financial management. This article consists of seven parts: the first part is the introduction, mainly introduces the research background and significance, the domestic and foreign research present situation, the research content and the method, the research thought, the second part is the related concept and the basic theory combing; The third part is the introduction of ZS Company, the fourth part is the diagnosis and analysis of ZS Company. First of all, through pest, Porter five-force model SWOT analysis from the macro environment, industry status, enterprise's own advantages and disadvantages of three aspects of strategic diagnosis, and then from the company's main accounting policies and estimates of changes in accounting diagnosis, Based on the horizontal and vertical comparison of solvency, profitability, operating capacity and cash flow, the paper finds out the shortcomings of its management, and forecasts the development trend of the company by using foreground analysis. The fifth part is the comprehensive evaluation of the company's financial diagnosis, the existing problems and cause analysis; the sixth part of the financial management optimization proposals; the seventh part is the conclusions and prospects. Based on the 2011-2015 annual report of ZS Company, this paper uses the Harvard Analysis Framework to diagnose and discover the financial problems, and finds out the reasons by using DuPont analysis and serial substitution method. The overall development of the company shows a positive and enterprising trend. To formulate a reasonable financial development strategy and management system, but individual indicators due to mergers and acquisitions in recent years, market economy development slowed down and other reasons such as fluctuations or bad development, inventory and accounts receivable turnover rate is low; The implementation of product development strategy is unsatisfactory, the conversion rate of R & D investment has not greatly increased the market share of the company; the cost control ability is weak; the merger and acquisition of the company makes the short-term solvency weakened and the debt repayment risk increased. This requires the company to formulate financial strategy optimization design, improve financial accounting management and disclosure, improve the financial performance and operational efficiency of the company, research and development and internal and external resources in coordination with the financial prospects forecast, comprehensive consideration of four aspects, Layer by layer gives concrete opinions. In this paper, the author summarizes the enlightenment, finds out the development direction of ZS company, and gives reference to the management of other pharmaceutical enterprises.
【學位授予單位】：廣東工業(yè)大學
【學位級別】：碩士
【學位授予年份】：2017
【分類號】：F406.7;F426.72

【參考文獻】

相關期刊論文 前10條

1 江玲;溫馨;夏志俊;朱斐;張琪峰;胡宇;;我國創(chuàng)新醫(yī)療器械發(fā)展宏觀環(huán)境分析——基于PEST模型[J];中國衛(wèi)生事業(yè)管理;2016年07期

2 滑笑盈;;企業(yè)財務診斷指標體系探究[J];現代商貿工業(yè);2015年22期

3 吉欣;;基于哈佛分析框架的企業(yè)財務報告分析——以哈藥股份為例[J];經營管理者;2015年31期

4 林春洋;;企業(yè)財務診斷簡析[J];中國集體經濟;2015年07期

5 馬琳;;中小企業(yè)財務管理能力評價體系研究[J];中國注冊會計師;2015年01期

6 胡水清;;運用財務戰(zhàn)略思維提升醫(yī)院財務管理效力[J];中國衛(wèi)生經濟;2014年07期

7 吳麗玲;張合振;吳添玲;;財務診斷及MCS模型應用研究[J];財會通訊;2014年02期

8 王瑞祥;;報表分析以云南白藥為例[J];商;2013年08期

9 方法林;;基于波特五力模型分析的旅游餐飲業(yè)發(fā)展策略探討[J];商業(yè)經濟;2013年01期

10 張杰;;企業(yè)財務診斷方法研究[J];行政事業(yè)資產與財務;2012年08期

相關博士學位論文 前2條

1 劉名旭;企業(yè)財務柔性研究[D];西南財經大學;2014年

2 白芳;基于企業(yè)生命周期視角的財務戰(zhàn)略和行為研究[D];西南財經大學;2013年

相關碩士學位論文 前5條

1 申麗姝;ZSJR公司財務分析與評價研究[D];西南交通大學;2015年

2 李卓;基于哈佛分析框架對中國電信運營業(yè)財務分析[D];財政部財政科學研究所;2013年

3 列柏洪;哈佛分析框架在廣州白云山制藥股份有限公司的應用研究[D];廣東商學院;2013年

4 滕忠路;哈佛分析框架在海信電器財務分析中的運用[D];蘭州大學;2013年

5 劉倩;兗州煤業(yè)股份有限公司發(fā)展戰(zhàn)略研究[D];山東大學;2012年

，

本文編號：2111484